By Josh White
Date: Monday 12 Feb 2024
(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.
By Josh White
Date: Tuesday 05 Dec 2023
(Sharecast News) - Cancer therapeutics-focussed life science company ValiRx announced on Tuesday that its subsidiary ValiSeek has entered into an exclusive option agreement with Ambrose Healthcare, a private UK-based pharmaceutical company.
By Josh White
Date: Friday 10 Nov 2023
(Sharecast News) - Life science company ValiRx announced a new partnership with StingRay Bio on Friday, aiming to explore a promising lead series of drug candidates designed for oncology applications.
Currency | UK Pounds |
Share Price | 3.55p |
Change Today | -0.30p |
% Change | -7.79 % |
52 Week High | 14.13 |
52 Week Low | 3.50 |
Volume | 888,756 |
Shares Issued | 132.35m |
Market Cap | £4.70m |
RiskGrade | 435 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:19 | 20,000 @ 3.59p |
16:15 | 13,380 @ 3.55p |
16:05 | 36,000 @ 3.55p |
16:02 | 60,340 @ 3.51p |
16:01 | 250,000 @ 3.59p |
You are here: research